Overview
Contraindications
When this intervention should not be used
GVOKE and GVOKE VialDx are contraindicated in patients with: 5.8 [see Warnings and Precautions ()] GVOKE VialDx for use as a diagnostic aid is also contraindicated in patients with glucagonoma because of risk of hypoglycemia • 5.1 [see Warnings and Precautions ()] Pheochromocytoma because of the ris
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
65 trials linked to this intervention
Recent Trials
Diagnosing and Treating Low Blood Sugar Levels
Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY)
Continuous Subcutaneous Infusion of Pramlintide and Insulin
Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.
Insulin Analogues and Severe Hypoglycaemia
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Glucagon (substance)
- SNOMED CT
- 66603002
- UMLS CUI
- C0017687
- RxNorm CUI
- 4832
- Labeler
- Xeris Pharmaceuticals, Inc.
Clinical Data
This intervention maps to 7 entities in the Healos knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.